Live Breaking News & Updates on Biopharma Trading Down|Page 8

Stay updated with breaking news from Biopharma trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Benitec Biopharma (NASDAQ:BNTC) Share Price Crosses Below 50-Day Moving Average of $4.97

Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $4.97 and traded as low as $2.36. Benitec Biopharma shares last traded at $2.40, with a volume of 62,701 shares trading hands. Benitec Biopharma Trading Down […] ....

Benitec Biopharma , Morgan Stanley , Renaissance Technologies , Virtu Financial , Benitec Biopharma Company Profile , Benitec Biopharma Inc , Millennium Management , Get Free Report , Biopharma Trading Down , Biopharma Inc , Benitec Biopharma Daily , Nasdaq Bntc ,

Kiromic BioPharma, Inc. (NASDAQ:KRBP) Short Interest Down 28.3% in June

Kiromic BioPharma, Inc. (NASDAQ:KRBP – Get Free Report) was the target of a significant decrease in short interest during the month of June. As of June 30th, there was short interest totalling 29,600 shares, a decrease of 28.3% from the June 15th total of 41,300 shares. Currently, 2.6% of the shares of the company are […] ....

Kiromic Biopharma , Susquehanna International Group , Kiromic Biopharma Company Profile , Securities Exchange Commission , Kiromic Biopharma Inc , Get Free Report , Biopharma Trading Down , International Group , Free Report , Kiromic Biopharma Daily , Nasdaq Krbp ,

Hillstream BioPharma (NASDAQ:HILS) Lowered to "Neutral" at Dawson James

Dawson James lowered shares of Hillstream BioPharma (NASDAQ:HILS – Free Report) from a buy rating to a neutral rating in a research note published on Monday, MarketBeat reports. Hillstream BioPharma Trading Down 4.3 % Shares of HILS stock opened at $0.38 on Monday. The firm has a fifty day simple moving average of $0.38 and […] ....

Dawson James , Hillstream Biopharma , Geode Capital Management , Hillstream Biopharma Inc , Hillstream Biopharma Company Profile , Citadel Advisors , Free Report , Biopharma Trading Down , Get Free Report , Street Group , Capital Management , Hillstream Biopharma Daily , Nasdaq Hils ,

Vor Biopharma Inc. (NYSE:VOR) Receives $16.19 Average PT from Analysts

Vor Biopharma Inc. (NYSE:VOR – Get Rating) has been assigned an average recommendation of “Buy” from the seven ratings firms that are covering the company, MarketBeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts that have issued a report on the stock in […] ....

United States , Stifel Nicolaus , Vor Biopharma Inc , Jump Financial , Denali Advisors , Vor Biopharma Company Profile , America Corp , Vor Biopharma , Get Rating , Jane Street Group , Biopharma Trading Down , Vor Biopharma Daily , Nyse Vor ,

Hillstream BioPharma, Inc. (NASDAQ:HILS) Sees Large Increase in Short Interest

Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Rating) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 343,000 shares, a growth of 30.1% from the May 15th total of 263,600 shares. Currently, 9.6% of the shares of the company are short […] ....

Hillstream Biopharma , Dawson James , Hillstream Biopharma Inc , Citadel Advisors , Geode Capital Management , Hillstream Biopharma Company Profile , Get Rating , Street Group , Capital Management , Biopharma Trading Down , Hillstream Biopharma Daily ,